Targetp53 binding protein(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Johnson & Johnson Pharmaceutical Research & Development
Affinity DataIC50: 400nMAssay Description:Binding assay using 1,4-benzodiazepine-2,5-dione (BZD) scaffold and HDM2-p53 protein.More data for this Ligand-Target Pair
Targetp53 binding protein(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Johnson & Johnson Pharmaceutical Research & Development
Affinity DataIC50: 1.00E+3nMAssay Description:Binding assay using 1,4-benzodiazepine-2,5-dione (BZD) scaffold and HDM2-p53 protein.More data for this Ligand-Target Pair
Targetp53 binding protein(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Johnson & Johnson Pharmaceutical Research & Development
Affinity DataIC50: 1.70E+3nMAssay Description:Binding assay using 1,4-benzodiazepine-2,5-dione (BZD) scaffold and HDM2-p53 protein.More data for this Ligand-Target Pair
Targetp53 binding protein(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Johnson & Johnson Pharmaceutical Research & Development
Affinity DataIC50: 3.80E+3nMAssay Description:Binding assay using 1,4-benzodiazepine-2,5-dione (BZD) scaffold and HDM2-p53 protein.More data for this Ligand-Target Pair
Targetp53 binding protein(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Johnson & Johnson Pharmaceutical Research & Development
Affinity DataIC50: 2.90E+4nMAssay Description:Binding assay using 1,4-benzodiazepine-2,5-dione (BZD) scaffold and HDM2-p53 protein.More data for this Ligand-Target Pair
Targetp53 binding protein(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Johnson & Johnson Pharmaceutical Research & Development
Affinity DataIC50: >1.25E+5nMAssay Description:Binding assay using 1,4-benzodiazepine-2,5-dione (BZD) scaffold and HDM2-p53 protein.More data for this Ligand-Target Pair